Skip to main content

Alpenglow Biosciences

Seattle, United States

Alpenglow Biosciences is an end-to-end 3D pathology platform that aims to accelerate drug development and improve clinical diagnostics.

$250K raised
Jan 2026
Undisclosed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alpenglow Biosciences

How much funding has Alpenglow Biosciences raised?
Alpenglow Biosciences has raised $250K in total funding. The most recent round was Undisclosed. The last funding was announced in January 2026.
Who are Alpenglow Biosciences's investors?
Alpenglow Biosciences's investors include Creative Destruction Lab, Dynamk Capital, National Institute of Health, Andy Hill Cancer Research Endowment (CARE) Fund, Mike Rice.
Where is Alpenglow Biosciences headquartered?
Alpenglow Biosciences is headquartered in Seattle, United States.
What does Alpenglow Biosciences do?
Alpenglow Biosciences is an end-to-end 3D pathology platform that aims to accelerate drug development and improve clinical diagnostics.
What stage is Alpenglow Biosciences at?
Alpenglow Biosciences is at the Undisclosed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Alpenglow Biosciences — Funding & Investors." VCBacked, January 8, 2026, https://www.vcbacked.co/company/alpenglow-biosciences. Accessed July 3, 2026.
APA
VCBacked. (2026). Alpenglow Biosciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/alpenglow-biosciences
Wikipedia (cite web)
{{cite web |title=Alpenglow Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/alpenglow-biosciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .